Article

Leben Suspended After UFC 138

LEBEN SUSPENDED FOR ONE YEAR AFTER FAILING UFC® 138 DRUG TEST
Zuffa, LLC, owner of the Ultimate Fighting Championship® (“the UFC®”), today released information stating that middleweight fighter Chris Leben tested positive for Oxycodone and Oxymorphone following his Nov. 5  loss to Mark Munoz in the main event of UFC® 138 in Birmingham, England.

As a result of the positive test, Leben will be suspended from fighting for one (1) year.

“I like Chris and I want him to do well, but based on his actions, he's been suspended for one year,” UFC President Dana White said. “If he needs professional help, we are going to be there for him. We want to see him succeed not only in the Octagon, but in his personal life.”

“I would like to make it known that I fully accept this suspension and apologize for embarrassing the UFC, my friends and family, and sport of mixed martial arts,” Leben said. “I’m learning that I’m my own worst enemy sometimes. I can’t succeed in the Octagon or in life behaving this way. I’ve got to make some real changes over the next year and I’m going to focus on getting my life and career back on track. Again, I’m sorry to the UFC and fans that’ve supported me since my days on The Ultimate Fighter.”

The remaining 19 fighters on the UFC® 138 card all passed their post fight drug tests.
 

Media

Recent
Michael Bisping believes he is still one of the best in the world. Don't miss Bisping Saturday against Kelvin Gastelum in the main event of Fight Night Shanghai.
24/11/2017
The former middleweight champ returns after just three weeks since his last fight to face rising star kelvin Gastelum in the main event of Fight Night Shanghai. You can watch it for free with a free trial of UFC FIGHT PASS.
24/11/2017
Kelvin Gastelum believes he can compete with the elite and he'll attempt to prove that on Saturday against former champion Michael Bisping at Fight Night Shanghai.
24/11/2017
Watch the highlights from Fight Night Shanghai's official weigh-in, featuring Micheal Bisping and Kelvin Gastelum.
24/11/2017